Infusion and Injection Services Administered in Unregulated Space
Customize your policy alerts
Sign up for marylandphysicianscarempc Policy RX.PA.070.MPC alerts
Get alerted when Policy RX.PA.070.MPC changes without checking for updates manually.
Monitor payer policy activity
Defines Maryland Physicians Care requirements for site-of-care determination and prior authorization for outpatient infusion and injection services for Maryland Medicaid members, applying to participating and non-participating providers and infusion/home infusion service providers.
Addition of Eculizumab biosimilar products and Vyvgart Hytrulo.
Removal of acute therapy medications - antibiotics, IV iron products and Lemtrada.
Removal of Botox products from restriction.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.